JP2014100148A5 - - Google Patents

Download PDF

Info

Publication number
JP2014100148A5
JP2014100148A5 JP2014045879A JP2014045879A JP2014100148A5 JP 2014100148 A5 JP2014100148 A5 JP 2014100148A5 JP 2014045879 A JP2014045879 A JP 2014045879A JP 2014045879 A JP2014045879 A JP 2014045879A JP 2014100148 A5 JP2014100148 A5 JP 2014100148A5
Authority
JP
Japan
Prior art keywords
cell culture
cell
culture supernatant
cells
heterologous protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014045879A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014100148A (ja
JP5890854B2 (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2014100148A publication Critical patent/JP2014100148A/ja
Publication of JP2014100148A5 publication Critical patent/JP2014100148A5/ja
Application granted granted Critical
Publication of JP5890854B2 publication Critical patent/JP5890854B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014045879A 2007-12-27 2014-03-10 細胞培養プロセス Active JP5890854B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US932807P 2007-12-27 2007-12-27
US61/009,328 2007-12-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2010540844A Division JP5727790B2 (ja) 2007-12-27 2008-12-22 細胞培養プロセス

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2015207654A Division JP2016013140A (ja) 2007-12-27 2015-10-22 細胞培養プロセス

Publications (3)

Publication Number Publication Date
JP2014100148A JP2014100148A (ja) 2014-06-05
JP2014100148A5 true JP2014100148A5 (enExample) 2015-04-09
JP5890854B2 JP5890854B2 (ja) 2016-03-22

Family

ID=40350258

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2010540844A Active JP5727790B2 (ja) 2007-12-27 2008-12-22 細胞培養プロセス
JP2014045879A Active JP5890854B2 (ja) 2007-12-27 2014-03-10 細胞培養プロセス
JP2015207654A Withdrawn JP2016013140A (ja) 2007-12-27 2015-10-22 細胞培養プロセス

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2010540844A Active JP5727790B2 (ja) 2007-12-27 2008-12-22 細胞培養プロセス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2015207654A Withdrawn JP2016013140A (ja) 2007-12-27 2015-10-22 細胞培養プロセス

Country Status (21)

Country Link
US (2) US9359629B2 (enExample)
EP (4) EP3255152A1 (enExample)
JP (3) JP5727790B2 (enExample)
KR (4) KR20180005287A (enExample)
CN (2) CN106222220A (enExample)
AR (2) AR069956A1 (enExample)
AU (1) AU2008345231B2 (enExample)
BR (1) BR122019022434B8 (enExample)
CA (1) CA2709890A1 (enExample)
DK (3) DK2235197T3 (enExample)
ES (3) ES2647294T3 (enExample)
HK (1) HK1246827A1 (enExample)
HR (3) HRP20171375T1 (enExample)
HU (2) HUE036712T2 (enExample)
MX (2) MX343269B (enExample)
NZ (1) NZ586250A (enExample)
PL (3) PL2235197T3 (enExample)
PT (3) PT2235197T (enExample)
SG (2) SG10201503304RA (enExample)
SI (3) SI2574676T1 (enExample)
WO (1) WO2009086309A2 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2527425A1 (en) 2006-09-13 2012-11-28 Abbott Laboratories Cell culture improvements
US8911964B2 (en) 2006-09-13 2014-12-16 Abbvie Inc. Fed-batch method of making human anti-TNF-alpha antibody
SI4269578T1 (sl) 2008-03-06 2024-07-31 Halozyme, Inc. Sestava topne hialuronidaze
TW201024318A (en) 2008-10-20 2010-07-01 Abbott Lab Isolation and purification of antibodies using protein A affinity chromatography
NZ592097A (en) 2008-10-20 2013-01-25 Abbott Lab Viral inactivation during purification of il-12 and il-18 antibodies
SG178194A1 (en) 2009-07-31 2012-03-29 Baxter Int Cell culture medium for adamts protein expression
US8580554B2 (en) * 2009-07-31 2013-11-12 Baxter International Inc. Method of producing a polypeptide or virus of interest in a continuous cell culture
HUE11738351T2 (hu) * 2010-07-08 2019-03-28 Baxalta GmbH Eljárás rekombináns ADAMTS13 elõállítására sejttenyészetben
WO2012122611A1 (en) * 2011-03-11 2012-09-20 Universidade De São Paulo - Usp Method for the production of recombinant human factor viii
EP2511293A1 (en) 2011-04-13 2012-10-17 LEK Pharmaceuticals d.d. A method for controlling the main complex N-glycan structures and the acidic variants and variability in bioprocesses producing recombinant proteins
US9062106B2 (en) 2011-04-27 2015-06-23 Abbvie Inc. Methods for controlling the galactosylation profile of recombinantly-expressed proteins
US9067990B2 (en) 2013-03-14 2015-06-30 Abbvie, Inc. Protein purification using displacement chromatography
US9334319B2 (en) 2012-04-20 2016-05-10 Abbvie Inc. Low acidic species compositions
US9181572B2 (en) 2012-04-20 2015-11-10 Abbvie, Inc. Methods to modulate lysine variant distribution
US9249182B2 (en) 2012-05-24 2016-02-02 Abbvie, Inc. Purification of antibodies using hydrophobic interaction chromatography
EP2890782A1 (en) 2012-09-02 2015-07-08 AbbVie Inc. Methods to control protein heterogeneity
US9512214B2 (en) 2012-09-02 2016-12-06 Abbvie, Inc. Methods to control protein heterogeneity
SG11201507230PA (en) 2013-03-12 2015-10-29 Abbvie Inc Human antibodies that bind human tnf-alpha and methods of preparing the same
US9017687B1 (en) 2013-10-18 2015-04-28 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same using displacement chromatography
WO2014159579A1 (en) 2013-03-14 2014-10-02 Abbvie Inc. MUTATED ANTI-TNFα ANTIBODIES AND METHODS OF THEIR USE
WO2014151878A2 (en) 2013-03-14 2014-09-25 Abbvie Inc. Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides
KR20150026024A (ko) * 2013-08-30 2015-03-11 한미약품 주식회사 인간 혈액응고 7인자 유도체의 대량 생산 방법
WO2015051293A2 (en) 2013-10-04 2015-04-09 Abbvie, Inc. Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins
US9085618B2 (en) 2013-10-18 2015-07-21 Abbvie, Inc. Low acidic species compositions and methods for producing and using the same
US8946395B1 (en) 2013-10-18 2015-02-03 Abbvie Inc. Purification of proteins using hydrophobic interaction chromatography
US9181337B2 (en) 2013-10-18 2015-11-10 Abbvie, Inc. Modulated lysine variant species compositions and methods for producing and using the same
US20150139988A1 (en) 2013-11-15 2015-05-21 Abbvie, Inc. Glycoengineered binding protein compositions
MX2016012288A (es) * 2014-03-25 2017-01-23 Genentech Inc Metodos para preparar un poloxamero para usar en medio de cultivo celular.
WO2015157335A1 (en) * 2014-04-10 2015-10-15 Bayer Healthcare Llc Compounded media powder formulation and method of preparation of liquid medium for cell culture
MX2016015971A (es) * 2014-06-03 2017-08-08 Lupin Ltd Proceso de cultivo celular para la producción de una proteína.
PT3926051T (pt) 2014-06-04 2024-06-20 Amgen Inc Métodos de colheita de culturas de células de mamíferos
RU2017145002A (ru) 2015-05-22 2019-06-24 Цсл Беринг Ленгнау Аг Способы получения модифицированного фактора фон виллебранда
JP7213180B2 (ja) * 2016-10-19 2023-01-26 エフ.ホフマン-ラ ロシュ アーゲー 免疫コンジュゲートを製造するための方法
CN114657118B (zh) * 2021-12-31 2023-12-01 广州齐志生物工程设备有限公司 一种2bs细胞在生物反应器内的多倍放大方法
EP4584299A2 (en) 2022-09-07 2025-07-16 Quantitative Biosciences, Inc. Fentanyl-specific single variable-domain antibodies and use in a continuous agglutination assay
CN116064409A (zh) * 2023-01-06 2023-05-05 四川阿思科力生物科技有限公司 一种大规模高产量细胞连续培养和收获的生产工艺
WO2024226439A1 (en) 2023-04-24 2024-10-31 Quantitative Biosciences, Inc. Engineered biosensor strains of e. coli for continuous aerobic detection of analytes
WO2025128343A1 (en) 2023-12-11 2025-06-19 Just-Evotec Biologics, Inc. Protein expression using trans-splicing and split selectable markers

Family Cites Families (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456591A (en) 1981-06-25 1984-06-26 Baxter Travenol Laboratories, Inc. Therapeutic method for activating factor VII
SE8501050D0 (sv) 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
DE3683980D1 (de) 1985-04-12 1992-04-02 Genetics Inst Neue prokoagulierungsproteine.
GR860984B (en) * 1985-04-17 1986-08-18 Zymogenetics Inc Expression of factor vii and ix activities in mammalian cells
US5250421A (en) 1986-01-03 1993-10-05 Genetics Institute, Inc. Method for producing factor VIII:C-type proteins
US5422260A (en) 1986-05-29 1995-06-06 Genetics Institute, Inc. -Legal Affairs Human factor VIII:c muteins
IL86693A (en) 1987-06-12 1994-06-24 Stichting Centraal Lab Proteins with factor VIII activity, process for their preparation using genetically engineered cells and pharmaceutical compositions containing them
US5200510A (en) * 1987-06-16 1993-04-06 Zymogenetics, Inc. Method for purifying factor viii:c, von willebrand factor and complexes thereof
US4921792A (en) * 1987-11-27 1990-05-01 Miles Inc. Continuous cell dispersion, cultivation and substance recovery process
JPH0787799B2 (ja) * 1988-03-30 1995-09-27 森永製菓株式会社 モノクローナル抗体生産増強法
US6100050A (en) 1989-08-17 2000-08-08 Dade Behring Ag Factor VIII:Ca chromogenic assay
NL9000917A (nl) 1989-10-25 1991-05-16 Holland Biotechnology Farmaceutisch preparaat met endoproteolytische activiteit; werkwijze voor endoproteolytische processing van (precursor) eiwitten en voor de (micro) biologische bereiding van eiwitten.
US5580560A (en) 1989-11-13 1996-12-03 Novo Nordisk A/S Modified factor VII/VIIa
SE465222C5 (sv) 1989-12-15 1998-02-10 Pharmacia & Upjohn Ab Ett rekombinant, humant faktor VIII-derivat och förfarande för dess framställning
AT393356B (de) * 1989-12-22 1991-10-10 Immuno Ag Verfahren zur herstellung von fsme-virus-antigen
GB9022545D0 (en) * 1990-10-17 1990-11-28 Wellcome Found Culture medium
DK0574402T3 (da) 1990-11-26 1998-05-18 Chiron Corp Ekspression af PACE i værtsceller og fremgangsmåder til anvendelse deraf
US5997864A (en) 1995-06-07 1999-12-07 Novo Nordisk A/S Modified factor VII
WO1992015686A1 (en) 1991-02-28 1992-09-17 Zymogenetics, Inc. Modified factor vii
US5661008A (en) 1991-03-15 1997-08-26 Kabi Pharmacia Ab Recombinant human factor VIII derivatives
CZ290342B6 (cs) 1992-10-02 2002-07-17 Genetics Institute Inc. Kompozice stabilní při skladování, obsahující koagulační faktor VIII a neiontovou povrchově aktivní látku a způsob její výroby
AT403167B (de) 1994-11-14 1997-11-25 Immuno Ag Selektion und expression von fremdproteinen mittels eines selektions-amplifikations-systems
CA2238434A1 (en) * 1995-12-15 1997-06-19 Systemix, Inc. Method for obtaining retroviral vector supernatant having high transduction efficiency
AT403765B (de) 1996-04-12 1998-05-25 Immuno Ag Verfahren zur herstellung einer präparation enthaltend einen hochgereinigten komplex
WO1998000521A1 (fr) * 1996-06-28 1998-01-08 The Green Cross Corporation Milieux exempts de serum, methode de culture de cellules d'origine animale, et procede de production de substances physiologiquement actives
US5854021A (en) 1997-02-28 1998-12-29 Bayer Corporation Enhance protein production method
US5804420A (en) * 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
US6475725B1 (en) 1997-06-20 2002-11-05 Baxter Aktiengesellschaft Recombinant cell clones having increased stability and methods of making and using the same
AT407255B (de) 1997-06-20 2001-02-26 Immuno Ag Rekombinanter zellklon mit erhöhter stabilität in serum- und proteinfreiem medium und verfahren zur gewinnung des stabilen zellklons
US6017882A (en) 1997-10-23 2000-01-25 Regents Of The University Of Minnesota Modified vitamin K-dependent polypeptides
US6358703B1 (en) 1998-12-10 2002-03-19 Bayer Corporation Expression system for factor VIII
AU777972B2 (en) 1999-02-22 2004-11-04 Baxalta GmbH Novel albumin-free factor VIII formulations
WO2001003726A1 (en) 1999-07-13 2001-01-18 Biovitrum Ab Stable factor viii compositions
JP4451514B2 (ja) 1999-08-24 2010-04-14 財団法人化学及血清療法研究所 血液凝固第vii因子改変体
JP2001120262A (ja) * 1999-10-26 2001-05-08 Welfide Corp 生理活性物質の産生増強方法
SE518174C2 (sv) * 1999-11-16 2002-09-03 Appliedsensor Sweden Ab Detektionsförfarande av oönskad mikrobiell infektion i animaliecellodling
DE60138364D1 (de) 2000-02-11 2009-05-28 Bayer Healthcare Llc Gerinnungsfaktor vii oder viia konjugate
US6168941B1 (en) * 2000-04-07 2001-01-02 Genvec, Inc. Method of producing adenoviral vector stocks
WO2001083725A1 (en) 2000-05-03 2001-11-08 Novo Nordisk A/S Human coagulation factor vii variants
AU2001287550B2 (en) 2000-09-13 2007-03-22 Novo Nordisk Health Care Ag Human coagulation factor VII variants
US20040185535A1 (en) * 2003-03-21 2004-09-23 Giles Wilson Industrial-scale serum-free production of recombinant FVII in mammalian cells
AU2002218029A1 (en) 2000-11-09 2002-05-21 The Scripps Research Institute Modified factor viia
US6926894B2 (en) * 2000-11-22 2005-08-09 Baxter Aktiengesellschaft Composition exhibiting a von willebrand factor (vWF) protease activity comprising a polypeptide chain with the amino acid sequence AAGGILHLELLV
US20030040095A1 (en) * 2001-03-16 2003-02-27 Achille Arini Method for the production of pharmaceutically active recombinant proteins
KR20030085041A (ko) 2001-03-22 2003-11-01 노보 노르디스크 헬스 케어 악티엔게젤샤프트 응고 인자 ⅶ 유도체
JP2003047461A (ja) * 2001-07-31 2003-02-18 Astec:Kk アパタイトシ−トを用いた細胞の高密度細胞培養法及び培養装置、細胞培養モジュール
ES2357423T3 (es) * 2001-08-31 2011-04-26 Bayer Schering Pharma Aktiengesellschaft Unidad y procedimiento para realizar fermentación a alta densidad celular.
CZ2004427A3 (cs) 2001-09-27 2004-08-18 Novoánordiskáhealthácareáag Polypeptidy lidského koagulačního faktoru VII
EP1434857B1 (en) * 2001-10-02 2007-08-01 Novo Nordisk Health Care AG Method for production of recombinant proteins in eukaryote cells
ES2490590T3 (es) 2001-11-02 2014-09-04 Novo Nordisk Health Care Ag Polipéptidos de factor VII de coagulación humana
US20030119723A1 (en) 2001-11-09 2003-06-26 Rasmus Rojkjaer Pharmaceutical composition comprising factor VII polypeptides and PAI-1 polypeptides
WO2004005493A1 (en) * 2002-07-09 2004-01-15 Baxter International, Inc. Animal protein free media for cultivation of cells
JP4651536B2 (ja) * 2003-04-17 2011-03-16 田辺三菱製薬株式会社 組換えアンチトロンビンの製造方法
ES2456015T3 (es) * 2004-03-05 2014-04-21 Dsm Ip Assets B.V. Procedimiento para cultivar células mediante perfusión continua y flujo tangencial alternante
ATE541919T1 (de) * 2005-02-11 2012-02-15 Novo Nordisk Healthcare Ag Herstellung eines proteins in serumfreier zellkultur, die ein proteinhydrolysat aus pflanzen enthält
CA2633306A1 (en) 2006-01-04 2007-07-12 Baxter International Inc. Oligopeptide-free cell culture media
PL2157177T3 (pl) 2007-05-22 2013-12-31 Baxalta Inc Sposób preparatywnego oczyszczania ludzkiej furyny

Similar Documents

Publication Publication Date Title
JP2014100148A5 (enExample)
HRP20171495T1 (hr) Postupci s kulturama stanica
PH12015501837A1 (en) Manufacturing methods to control c-terminal lysine, galactose and sialic acid content in recominbinant proteins
EP4148121A3 (en) Cell-controlled perfusion in continuous culture
EP3916081A3 (en) Control of protein glycosylation by culture medium supplementation and cell culture process parameters
EA201690600A1 (ru) Метаболически оптимизированная клеточная культура
MX387489B (es) Cultivo de células de mamífero.
CL2011001926A1 (es) Biorreactor para el cultivo de celulas de mamiferos donde dicho biorreactor posee un volumen de al menos 4000 l y al menos un impulsor superior y al menos un impulsor de fondo, donde el impulsor superior es un impulsor de hidroplano; metodo de cultivo; sistema de bioreactor.
EA201270213A1 (ru) Способ получения полипептида или вируса, представляющих интерес, в непрерывной клеточной культуре
MX2021007433A (es) Metodos de cultivo de una celula de mamifero.
MX2016010236A (es) Modulacion del crecimiento celular y glucosilacion en la produccion de glucoproteina recombinante.
EA201501003A1 (ru) Солнечный биовегетарий
WO2015193811A3 (en) Production of 1-propanol
EP4446402A3 (en) Improved culture methods and devices for testing
CN205667179U (zh) 一种用于调节温度的水帘及采用该水帘的温室
CN201355950Y (zh) 一种农田环境臭氧浓度自动调控装置
CN101480142B (zh) 一种农田环境臭氧浓度自动调控装置
CN204803317U (zh) 一种新型环保藻类养殖装置
CN205556700U (zh) 一种用于肿瘤干细胞培养和成球的微孔芯片
CN204560308U (zh) 新型牛肝菌育苗养殖箱
CN205455831U (zh) 一种移动式农产品简易气调熏蒸筒
CN203284393U (zh) 一种生活污水处理用生化培养袋
CN204434619U (zh) 用于向螺旋藻提供照度的温度检测装置
Fischer et al. Simple shake flask cultivation of Komagataella phaffii with constant glycerol feed and online monitoring
CN202671444U (zh) 一种堆制有机肥的生产设备